Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Mar;125(3):210-5.
doi: 10.1016/j.thromres.2009.11.028.

Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis

Affiliations
Review

Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis

Evi Stavrou et al. Thromb Res. 2010 Mar.

Abstract

Factor XII (FXII) is a coagulation protein that is essential for surface-activated blood coagulation tests but whose deficiency is not associated with bleeding. For over forty years, investigators in hemostasis have not considered FXII important because its deficiency is not associated with bleeding. It is because there is a dichotomy between abnormal laboratory assay findings due to FXII deficiency and clinical hemostasis that investigators sought explanations for physiologic hemostasis independent of FXII. FXII is a multidomain protein that contains two fibronectin binding consensual sequences, two epidermal growth factor regions, a kringle region, a proline-rich domain, and a catalytic domain that when proteolyzed turns into a plasma serine protease. Recent investigations with FXII deleted mice that are protected from thrombosis indicate that it contributes to the extent of developing thrombus in the intravascular compartment. These findings suggest that it has a role in thrombus formation without influencing hemostasis. Last, FXII has been newly appreciated to be a growth factor that may influence tissue injury repair and angiogenesis. These combined studies suggest that FXII may become a pharmacologic target to reduce arterial thrombosis risk and promote cell repair after injury, without influencing hemostasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structural Basis of FXII Function: FXII is divided into several domains. Top structure: amino acid sequence; bottom structure, linear diagram color coding each of the regions on the protein. Amino acids -19-1: leader peptide, 1–88: fibronectin type II domain, 94–131: EGF-like domain, 133–173: fibronectin type I domain, 174–210: EGF-like domain, 215–295: kringle domain, 296–349: proline-rich region, 354–596: catalytic domain or light chain. Amino acids 1–353 are the so-called heavy chain. Each of these areas is highlighted in the same color as the linear cartoon below it. This figure is adapted from Cool and MacGillivray [5].

Similar articles

Cited by

References

    1. Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955 Apr;34(4):602–613. - PMC - PubMed
    1. Davie EW, Ratnoff OD. Waterfall Sequence for Intrinsic Blood Clotting. Science. 1964 Sep;18(145):1310–1312. - PubMed
    1. Ghebrehiwet B, Silverberg M, Kaplan AP. Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med. 1981 Mar 1;153(3):665–676. - PMC - PubMed
    1. Citarella F, Tripodi M, Fantoni A, Bernardi F, Romeo G, Rocchi M. Assignment of human coagulation factor XII (fXII) to chromosome 5 by cDNA hybridization to DNA from somatic cell hybrids. Hum Genet. 1988 Dec;80(4):397–398. - PubMed
    1. Cool DE, MacGillivray RT. Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region. J Biol Chem. 1987 Oct 5;262(28):13662–13673. - PubMed